HDI Global Insurance Company Launches a New Excess Liability Solution for Life Sciences
HDI Global Insurance Company has rolled out an excess Life Sciences Liability policy tailored to the complex realities of the life sciences sector. Built for organizations that need more protection on top of their primary coverage, the solution offers up to $10 million in capacity. It’s designed for a broad range of customers across biotechnology and medical device markets, where risks can evolve quickly and small details matter.
Coverage Focused on Real-World Life Sciences Risks
The policy delivers tailored protection that aligns with how life sciences businesses actually operate. Target classes include biotechnology companies, specialty pharmaceutical manufacturers, non-invasive and invasive medical device manufacturers, and blood plasma firms. It’s also structured with contract manufacturers and contract development and manufacturing organizations in mind, recognizing the pivotal role they play in today’s supply chains and product lifecycles.
A Clear Commitment to the Life Sciences Community
Marco Hensel, Chief Underwriting Officer at HDI Global Insurance Company, underscored the company’s focus on fit-for-purpose solutions in a demanding industry. “HDI is committed to providing our insureds with bespoke solutions within the life sciences segment,” Hensel said. The launch aligns with HDI’s broader strategy to deepen its presence in the region and to act as a true Partner in Transformation for clients navigating a fast-moving medical and technological landscape.
Experienced Leadership at the Helm
To lead the effort, HDI has appointed Brian Carlsen as Assistant Vice President and US Life Science Lead. Carlsen brings 16 years of underwriting experience, much of it concentrated in life sciences placements. Prior to joining HDI, he served as an Underwriting Manager at a Fortune 500 carrier—experience that equips him to balance technical detail with market context. He is also an alumnus of Fairfield University.
Building for Sustainable Growth in the US
Dani Maurer, Head of HDI’s Liability Global Risk Division, welcomed Carlsen to the team. “HDI is excited to have Brian join our US casualty team,” Maurer said. “His extensive experience with firms, ranging from small startups to large multinationals, will significantly contribute to our growth and product line expansion in the US market.” The goal is straightforward: expand intelligently, support clients at every stage, and keep pace with the sector’s rapid change.
Where to Learn More
Those interested in HDI’s expanded life sciences offerings can find additional details on the company’s official website. The new product underscores HDI’s ongoing commitment to the insurance needs of life sciences organizations and reflects its role as a global leader in the insurance industry by combining sector focus with meaningful capacity.
About HDI Global SE
HDI Global SE is a commercial and specialty lines insurer serving small and mid-sized enterprises, industrial firms, and corporate clients. Rooted in the European market yet operating internationally, HDI reaches more than 175 countries through its own branches and partner networks. Its teams develop solutions that are structured around each client’s specific risk profile and operational reality.
In the United States, HDI operates through three wholly owned subsidiaries: HDI Global Insurance Company, HDI Global Select Insurance Company, and HDI Specialty Insurance Company. Together, these entities provide comprehensive coverage options so clients can access the tailored protection they need within a single, coordinated portfolio.
HDI manages more than 5,000 international programs, helping multinational clients maintain compliant, consistent coverage across borders. As part of the Talanx Group, HDI has been a reliable insurer for decades, reporting strong revenue performance in recent years and holding an A+/stable financial strength rating from Standard & Poor’s.
Frequently Asked Questions
What is HDI’s excess Life Sciences Liability policy?
It’s an insurance solution designed for life sciences businesses that need additional protection beyond their primary liability coverage. The policy is built around the sector’s specific exposures and offers up to $10 million in capacity.
Which types of companies are a fit for this coverage?
The policy targets biotechnology firms, specialty pharmaceutical manufacturers, non-invasive and invasive medical device manufacturers, and blood plasma firms. It also supports contract manufacturers and contract development and manufacturing organizations.
What is HDI’s aim with this launch?
HDI’s goal is to provide bespoke, sector-aware solutions for the life sciences segment and to support clients as a Partner in Transformation while expanding its footprint in the region.
Who is leading the life sciences initiative in the US?
Brian Carlsen serves as Assistant Vice President and US Life Science Lead. He brings 16 years of underwriting experience, including leadership at a Fortune 500 carrier, and is a Fairfield University alumnus.
How can I find more details about the product?
Further information about HDI’s life sciences offerings is available on the company’s official website, including specifics on coverage focus and market availability.
